Retrophin Begins Dosing Patients in Trial of RE-024

Retrophin Begins Dosing Patients in Trial of RE-024

Retrophin has begun dosing patients in a clinical trial assessing the safety and efficacy of RE-024 to treat pantothenate kinase-associated neurodegeneration (PKAN), a rare, genetic neurological disorder. “The dosing of the first patient in the phase 3 FORT Study is an important milestone for the RE-024 program,” said Bill Rote, head of research and development for Retrophin, “as it continues our progress towards developing a treatment with the potential to […]

Read More ˃
Freightcar America Names James Meyer as New CEO

Freightcar America Names James Meyer as New CEO

Freightcar America has named James Meyer as president and CEO, effective July 31. Meyer will succeed Joseph McNeely, who will leave the company by mutual consent to pursue new opportunities. Meyer, 56, joins the company from Commercial Specialty Truck Holdings, LLC, a commercial truck manufacturer, where he has served as chairman of the board and has been an investor and advisor since 2015. From 2012 to 2015, he served as […]

Read More ˃